This study is looking at an intervention called CB-sleep for adults aged 18 to 40 who have Type 1 diabetes. CB-sleep is a behavioral program that uses motivational interviewing and behavior change principles to help improve sleep. The goal is to see if CB-sleep can improve sleep health and lower glycated hemoglobin (HbA1C), which is a measure of your average blood sugar over 2-3 months. You can join if you have Type 1 diabetes for at least one year and have sleep issues. You cannot join if you don't speak English or if your A1C is already very well controlled (below 7%) or very high (above 80% time in glucose range). The study plans to enroll 300 people, but the current recruitment status is unclear.

Study design

This is a randomized controlled trial, meaning you would be randomly assigned to either the CB-sleep intervention or an enhanced usual care group. The study plans to enroll 300 participants.

What's involved

You would complete questionnaires and have 14 days of sleep and glucose monitoring at the start. You would then be assigned to a group and have follow-up measurements at 3, 6, and 9 months.

Compensation

Not stated in the trial record.

Follow-up

You would be followed for 9 months after the intervention begins, with measurements taken at 3, 6, and 9 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.